SAR446523 clinical trials

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

This study is testing a new drug, SAR446523, for people in the UK with a type of blood cancer called myeloma that has come back or is no longer responding to usual treatments. It's looking at how safe the drug is and how well it works.